President-elect Donald Trump intends to nominate Sen. Jeff Sessions to be his next Attorney General, the presidential transition announced Friday.
Sessions, 69, is currently serving his fourth Senate term and was the first sitting senator to endorse Trump. During Trump’s campaign, he served as a key validator from within the Republican establishment at critical times and urged Republicans to coalesce around Trump.
Sessions had been in consideration for several Cabinet positions, and as one of Trump’s earliest and most loyal supporters.
“Jeff has been a highly respected member of the US Senate for 20 years,” Trump said in a statement. “He is a world-class legal mind and considered a truly great Attorney General and US Attorney in the state of Alabama. Jeff is greatly admired by legal scholars and virtually everyone who knows him.”
United by their hardline stance against illegal immigration, Sessions helped Trump craft his campaign’s national security policy. His top policy adviser, Stephen Miller, also joined Trump’s campaign.
Sessions was one of President Barack Obama’s fiercest opponents, voting against his nominees to the Supreme Court from his post on the Judiciary Committee and opposing Obama’s other major domestic initiatives.
Full content: CNN
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas